SHANGHAI JUNSHI BIOSCIENCES CO., LTD. - H SHARES (1877)

JUNSHI BIO (1877)

HK$30.740

+1.240 (+4.20%)

Prev. Close is the most recent non-zero closing value or settlement price.PREV. CLOSE
HK$29.500

Open price is the first traded price of the day. The opening price is reported after 09:20:00 HKT.OPEN
HK$29.980

TURNOVER
HK$504.68M

VOLUME
16.43M

MKT CAP
HK$8.00BH Shares only

LOT SIZE
200

BID
HK$30.740

ASK
HK$30.820

EPS
-

P/E
-

DIV YIELD
-

	INTRA-DAY	52W
High	HK$31.720	HK$32.580
Low	HK$29.580	HK$9.720

Information is available after the market opens and is delayed by at least 15 minutes.

Updated: 13 Aug 2025 16:08 HKT

Stock Quote Lookup

Export to Excel

1min

5min

15min

Hourly

Prev. Close
29.500

All charts use the last traded price or closing price.

View All on HKEXnews

COMPANY ANNOUNCEMENTS

COMPANY PROFILE

Shanghai Junshi Biosciences Co Ltd is a China-based company mainly engaged in innovation-driven biopharmaceutical business. The Company's main businesses are the discovery, clinical research and development of innovative drugs. The Company's main products include teriprizumab injection, Etesevimab, adalimumab injection and other drugs, which are used to treat malignant tumors, autoimmune system diseases, chronic metabolic diseases, nervous system diseases and infectious diseases. The Company is also engaged in the clinical research and development of recombinant humanized anti-PCSK9 monoclonal antibody injection and other drugs. The Company provides its products for domestic and overseas markets. *

260,295,700 (as at 31 Jul 2025)

Industry Healthcare - Pharmaceuticals & Biotechnology - Biotechnology Health Care

Listing Date 24 Dec 2018

Financial Year Ends 31 Dec 2024

Chairman Xiong Jun

Principal Office Room 602
No. 781, Cai Lun Road
China (Shanghai) Pilot
Free Trade Zone, the PRC

Place of Incorporation PRC

Listing Category Primary Listing

Registrar Tricor Investor Services Ltd.

Disclaimer

The industry and sector classification results of the Hang Seng Industry Classification System referred to in this section (“HSICS Information”) is provided by Hang Seng Indexes Company Limited. Neither Hang Seng Indexes Company Limited nor any of its holding companies and subsidiaries nor HKEX Information Services Limited nor any of its holding companies and subsidiaries provides any warranties of any kind in relation to such HSICS Information (including, without limitation, that the HSICS Information is fit or suitable for any purpose, or that any person will obtain any particular results by using or relying on the HSICS Information) or accepts any responsibilities for its accuracy, completeness, timeliness and/or consistency, or for any loss or damage whatsoever and howsoever suffered or incurred by any person. With the use of or the access to the HSICS Information any person receiving any HSICS Information from HKEX Information Services Limited or any of its holding companies or subsidiaries irrevocably and unconditionally accepts and agrees to be bound by this disclaimer.

Important Notes - dissemination of HSICS Information

Please contact Hang Seng Indexes Company Limited and enter into a licence agreement with it before you further disseminate any of the industry and sector classification results of the Hang Seng Industry Classification System to any other person.

Disclaimer

The Information is provided without warranties of any kind, either expressed or implied, including warranties of merchantability, merchantable quality, title, fitness for a particular purpose, security, accuracy and non-infringement. China Securities Index Co., Ltd. endeavors to ensure the accuracy and reliability of the information provided, but does not guarantee its accuracy and reliability and accepts no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions or for any reliance placed on such information.

Notes on Number of Issued Shares / Issued Units

1. Listed issuers are required by Listing Rules to publish a Monthly Return to provide an update on a fixed monthly basis the movement of its issued capital by 8:30am of the fifth business day following the end of each calendar month. Listed issuers are also required to publish a Next Day Disclosure Return in respect of changes in issued share capital, in some cases by 8:30am of the next business day and in other cases subject to a 5% de minimis threshold and certain other criteria (e.g. aggregation). Please refer to the Listing Rules (MAIN / GEM) for details.

2. Please visit the HKEXnews website to retrieve the latest Monthly Returns and Next Day Disclosure Returns for the most up-to-date number of issued shares / issued units disclosed by the listed issuers.

3. In most cases, the number of issued shares / issued units presented here should be consistent with the latest figure disclosed by the listed issuers. Discrepancies could however arise due to one or more of the following reasons:

a. Updating time-lag

The number of issued shares / issued units presented is generally updated within 7 days after the Monthly Returns and Next Day Disclosure Returns published by the listed issuers on the HKEXnews website. Hence, the information presented here may not be the most up-to-date information submitted by the listed issuers as required under the Listing Rules.

b. Rights issues or bonus issues

The number of issued shares / issued units presented here will be adjusted with effect from the ex-date in the event of announced rights issues or announced bonus issues. In this case, both the number of issued shares / issued units before and after the adjustment will be presented.

c. Share splits or share consolidations

The number of issued shares / issued units presented here will be adjusted on the effective date in the event of share splits or share consolidations.

d. Conversion of convertible notes into shares

If the change of the number of issued shares / issued units is due to conversion of convertible bonds, the number of issued shares / issued units presented here may be updated based on the related company announcement.

4. For H-share companies, the number of issued shares refers to "H-shares" only.

5. For Depositary Receipts, the number of issued shares refers to the number of Hong Kong Depositary Receipts approved for listing only.

6. The compilation of market capitalisation by the Exchange is based on the number of issued shares updated as above.

7. For dual counter stocks, the number of issued shares is the aggregated total of both HKD and RMB shares.

8. For Stapled Securities, the number of issued shares (including the ordinary shares and preference shares) (or issued units) refers to the number of Stapled Securities (or number of units) approved for listing only.

Updated: 13 Aug 2025 19:05 HKT

* Company profile is provided by Refinitiv.

ENTITLEMENT

Date Announced	Ex-Date	Details	Financial Year End	Book Close Date	Payment date may be indicative only.Payment Date
27 Mar 2025	-	No Dividend for the period ended 2024/12/31	31 Dec 2024	-	-
30 Aug 2024	-	No Dividend for the period ended 2024/06/30	31 Dec 2024	-	-
28 Mar 2024	-	No Dividend for the period ended 2023/12/31	31 Dec 2023	-	-
30 Aug 2023	-	No Dividend for the period ended 2023/06/30	31 Dec 2023	-	-
30 Mar 2023	-	No Dividend for the period ended 2022/12/31	31 Dec 2022	-	-

Updated: 14 Aug 2025 01:15 HKT

Dividend details are sourced from Announcement Forms published on HKEXnews

See All

RELATED PRODUCTS

Code	Call / Put	Expiry	Strike	Last Price
No related products

Updated: